论文部分内容阅读
目的:评估康复新液治疗难治性消化性溃疡的临床疗效。方法:选取2013年4月-2014年5月我院收治的70例难治性消化性溃疡患者,将入选病例随机分成两组,每组35例,对照组采用奥美拉唑+阿莫西林胶囊+甲硝唑常规治疗方法进行治疗,观察组在此基础上采用康复新液进行治疗,观察两组治疗效果。结果:治疗一个月后,观察组治疗总有效率明显高于对照组(97.14%vs71.43%),p<0.05,有统计学意义。结论:康复新液用于治疗难治性消化性溃疡,临床效果显著,值得推广。
Objective: To evaluate the clinical efficacy of Kangfuxin solution in the treatment of refractory peptic ulcer. Methods: Seventy patients with refractory peptic ulcer admitted in our hospital from April 2013 to May 2014 were selected and randomly divided into two groups (n = 35 in each group). The patients in the control group were treated with omeprazole plus amoxicillin Capsule + metronidazole conventional treatment methods, the observation group on the basis of the rehabilitation of new fluid treatment, the two groups were observed. Results: After one month of treatment, the total effective rate of the observation group was significantly higher than that of the control group (97.14% vs 71.43%), p <0.05, with statistical significance. Conclusion: Kangfuxin solution is used in the treatment of refractory peptic ulcer. The clinical effect is significant and worthy of promotion.